Journal Top Ten, COLUMNS-Mold, May 2005
June 9, 2005
ARTICLE: "Antifungal therapy decreases sensitivity of the Aspergillus galactomannan enzyme immunoassay"
SUMMARY: Reported sensitivity of the galactomannan enzyme immunoassay as an early diagnostic test for invasive aspergillosis (IA) has been widely variable, ranging from 29 percent to 100 percent in earlier clinical studies. In this study, performance of the test was calculated in per-patient and per-test analyses in a large cohort of patients at high risk for IA from 2 North American centers. A total of 272 serum samples obtained from 46 patients with IA and 3005 serum samples obtained from …
UPCOMING CONFERENCES

HarrisMartin's Data Breach Litigation Conference
March 26, 2025 - Charlotte, NC
Omni Charlotte Hotel

HarrisMartin’s Artificial Stone Silicosis Epidemic Litigation Conference
April 08, 2025 - Long Beach, CA
The Westin Long Beach